Stock IdeasStrong Buy StocksStrong Buy Stocks from Top Wall Street AnalystsLatest stocks with a Strong Buy rating from the top performing 25% of analysts tracked by WallStreetZen
Stock IdeasStrong Buy Stocks
| Analyst / Firm | Company | Price | Rating | Price Target | Upside/Downside | Date |
|---|---|---|---|---|---|---|
Travere Therapeutics IncTVTX | $52.42 | Strong Buy | $72.00 | +37.35% | a day ago | |
Analyst RankingTop 6% #330 out of 5553 analysts Average Return+21.45% Win Rate54%67 out of 125 Risk vs RewardPoor Good Analyst ColorCanaccord Genuity's Edward Nash raised their price target on Travere Therapeutics (NASDAQ: TVTX) by 2.9% from $70 to $72 on 2026/11/05. The analyst maintained their Strong Buy rating on the stock. Travere Therapeutics reported its Q3 2026 earnings. Raising their estimates and price target, Nash pointed to the quarter's higher-than-expected Filspari revenue ($200.2M compared to the $170.3M consensus, noting, however, that the $(0.55) EPS missed the expected $(0.10). | ||||||
Tesla IncTSLA | $800.00 | Strong Buy | $850.00 | +6.25% | 2 days ago | |
Upgrade to Premium to View MoreStrong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts Already have access to Premium? Sign In | ||||||
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.